Menu Search

Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
EQS-Adhoc: thyssenkrupp AG: thyssenkrupp and EP Corporate Group enter into strategic partnershipEQS Newswire
EQS-Adhoc: ams-OSRAM AG: delivers solid Q1 revenues of EUR 847m, adj. EBIT margin of 5.2%, restructures microLED development, works on exiting 8-inch fab SLB, on track for positive FCF (after interest) in 2025EQS Newswire
EQS-News: PALFINGER AG: Outstanding results for PALFINGER AG in the first quarterEQS Newswire
Sopra Steria Group: Q1 2024 in Line With ForecastsBusiness Wire
EQS-News: BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest ratesEQS Newswire
EQS-Adhoc: BB Biotech AG publishes its interim reportEQS Newswire
EQS-Adhoc: ams-OSRAM AG: ams OSRAM has published the Annual Report 2023EQS Newswire
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in AfricaPR Newswire
AZZ Inc. Announces Pricing of its Public Offering of Common StockPR Newswire
Schneider Electric Launches All-In-One Battery Energy Storage System (BESS) for MicrogridsGlobeNewswire
„Aprangos” grupės 2024 m. 3 mėnesių tarpinė informacijaGlobeNewswire
Corbion: Q1 2024 Interim Management StatementGlobeNewswire
RIBER: Mise à disposition du rapport financier annuel 2023GlobeNewswire
Hexatronic Group AB (publ) Interim report January – March 2024GlobeNewswire
Lassila & Tikanoja plc: Interim Report 1 January–31 March 2024GlobeNewswire
Signify reports first quarter sales of EUR 1.5 billion, operational profitability of 8.3% and a free cash flow of EUR 80 millionGlobeNewswire
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertensionGlobeNewswire
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertensionGlobeNewswire
RNS announcements are delayed by up to an hour.
...